Pharmena S.A. (WSE:PHR)
Poland
· Delayed Price · Currency is PLN 3.460
-0.060 (-1.70%)
Mar 9, 2026, 12:10 PM CET
Pharmena Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1.58 | 0.27 | 0.3 | 0.3 | 15.21 | Upgrade
|
| Revenue Growth (YoY) | 488.43% | -10.37% | - | -98.04% | 53.16% | Upgrade
|
| Cost of Revenue | 0.26 | 0.07 | 0.3 | 0.21 | 6.79 | Upgrade
|
| Gross Profit | 1.31 | 0.2 | -0 | 0.09 | 8.43 | Upgrade
|
| Selling, General & Admin | 4.59 | 3.58 | 3.96 | 3.84 | 12.02 | Upgrade
|
| Other Operating Expenses | -0 | 0.03 | -36.77 | 0.31 | 0.47 | Upgrade
|
| Operating Expenses | 4.59 | 3.6 | -32.81 | 4.15 | 12.48 | Upgrade
|
| Operating Income | -3.28 | -3.4 | 32.81 | -4.06 | -4.05 | Upgrade
|
| Interest Expense | -0.02 | -0.04 | -0.37 | -0.66 | -0.27 | Upgrade
|
| Interest & Investment Income | 0.55 | 0.88 | 0.43 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0 | 0.07 | -0.01 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.14 | -0.24 | -0.17 | Upgrade
|
| EBT Excluding Unusual Items | -2.75 | -2.56 | 32.8 | -4.97 | -4.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.03 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.01 | 0.04 | Upgrade
|
| Other Unusual Items | - | 0.01 | 0.08 | - | 0.03 | Upgrade
|
| Pretax Income | -2.74 | -2.56 | 32.93 | -4.95 | -4.46 | Upgrade
|
| Income Tax Expense | 0.03 | -1.3 | 5.91 | 0.2 | 0.18 | Upgrade
|
| Earnings From Continuing Operations | -2.77 | -1.26 | 27.02 | -5.16 | -4.64 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 1.93 | 3.54 | - | Upgrade
|
| Net Income to Company | -2.77 | -1.26 | 28.95 | -1.62 | -4.64 | Upgrade
|
| Minority Interest in Earnings | - | - | -0.01 | 0.05 | 0.05 | Upgrade
|
| Net Income | -2.77 | -1.26 | 28.94 | -1.57 | -4.59 | Upgrade
|
| Net Income to Common | -2.77 | -1.26 | 28.94 | -1.57 | -4.59 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 1.25% | Upgrade
|
| EPS (Basic) | -0.25 | -0.11 | 2.60 | -0.14 | -0.41 | Upgrade
|
| EPS (Diluted) | -0.25 | -0.11 | 2.60 | -0.14 | -0.41 | Upgrade
|
| Free Cash Flow | -3.53 | -2.71 | 32.72 | 1.59 | -3.54 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.24 | 2.94 | 0.14 | -0.32 | Upgrade
|
| Dividend Per Share | - | 0.850 | 0.850 | - | - | Upgrade
|
| Gross Margin | 83.26% | 73.88% | -0.33% | 30.44% | 55.39% | Upgrade
|
| Operating Margin | -207.99% | -1269.78% | 10972.91% | -1358.19% | -26.65% | Upgrade
|
| Profit Margin | -175.59% | -470.90% | 9679.26% | -525.08% | -30.19% | Upgrade
|
| Free Cash Flow Margin | -223.65% | -1011.57% | 10942.48% | 532.78% | -23.30% | Upgrade
|
| EBITDA | -3.26 | -3.38 | 32.88 | -3.95 | -3.86 | Upgrade
|
| EBITDA Margin | -206.53% | - | 10997.66% | - | -25.35% | Upgrade
|
| D&A For EBITDA | 0.02 | 0.02 | 0.07 | 0.11 | 0.2 | Upgrade
|
| EBIT | -3.28 | -3.4 | 32.81 | -4.06 | -4.05 | Upgrade
|
| EBIT Margin | -207.99% | - | 10972.91% | - | -26.65% | Upgrade
|
| Effective Tax Rate | - | - | 17.94% | - | - | Upgrade
|
| Advertising Expenses | 0.07 | 0.03 | 0.18 | 0.06 | 0.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.